# Changelog

All notable changes to `dna_decode`. Format loosely follows [Keep a Changelog](https://keepachangelog.com/);
this is a solo research-tool repo so the granularity is per-release-theme, not per-PR.

## [0.3.0] — 2026-06-06

The "deterministic decoders win" release. The frozen-genome-embedding (NT mean-pool) thesis was tested
to a decisive conclusion and the project committed to deterministic, interpretable mechanism-feature
decoders as the shipping path.

### Added
- **Multi-drug deterministic AMR caller** (`dna-amr`). Extended from cipro-only to **ceftriaxone +
  tetracycline**, with per-drug validated rules baked into `dna_decode/eval/amr_rules.py::DRUG_RULE`:
  - ciprofloxacin — threshold 2 (QRDR point-mutations) — N=147 acc 0.939.
  - ceftriaxone — threshold 1 + **extended-spectrum subclass refinement** (CEPHALOSPORIN/CARBAPENEM;
    excludes intrinsic blaTEM-1/blaEC that are ampicillin-R not ceftriaxone-R) — N=60 acc 0.933.
  - tetracycline — threshold 1 (acquired tet genes) — N=12 acc 0.833 (small N, provisional).
  - gentamicin — threshold 1 by mechanism analogy, **not yet cohort-validated** (flagged in output).
  - `call_resistance(tsv, drug)` now auto-selects the per-drug rule; explicit threshold still overrides.
  - Validation: `wiki/dna_amr_multidrug_validation_2026-06-06.md`.
- **De-confound gate** (`dna_decode/eval/cohort_deconfound.py`) — within-lineage label-contrast
  precondition (3-state DE_CONFOUNDED/WARN/CONFOUNDED + promotability) for any embedding-vs-classical
  falsifier. The reusable guard against study==class confounding.
- **AMR embedding falsifier** (`scripts/amr_falsifier.py`) + **QRDR-POINT knowledge baseline**
  (`dna_decode/eval/point_baseline.py`) + within-lineage diagnostic.
- **dna-amr external validation** — held-out N=29 acc 0.862 / sens 0.882 / spec 0.833
  (`wiki/dna_amr_external_validation_2026-06-05.md`).
- **EP-6 carbon-utilization substrate infra** — `dna_decode/data/bacdive.py` loader +
  `scripts/bacdive_carbon_util_feasibility.py` census + `scripts/bacdive_li2023_to_long.py` adapter.

### Findings (recorded, not code)
- **AMR embedding thesis FALSIFIED on the cleanest substrate.** Cipro N=147 (de-confounded): NT-XGBoost
  0.914 beats k-mer (+8.9 pp) but **LOSES to QRDR-POINT 0.943**; NT within-lineage concordance = chance
  (0.605, p=0.365) → it learned lineage, not mechanism. Decision: `plans/AMR_embedding_niche_decision_2026-06-05.md`.
- **Carbon-utilization (EP-6) E. coli-INFEASIBLE.** Data acquired (Li et al. 2023 OSF jwkr7); E. coli
  slice = 27 strains, 0 carbon sources clear the ≥100 floor. The embedding-niche test needs a THIRD
  requirement beyond sampling-independent-label + no-catalog: **organism-specific depth at scale**.
  `wiki/bacdive_carbon_util_feasibility_2026-06-06.md`.

### Changed
- `dna-amr` CLI `--resistance-threshold` now defaults to the per-drug validated config (was hard-coded 2).
- README decoder table + `plans/Trait_Decoding_Roadmap.md` Phase 2/4 updated.

## [0.2.0] — 2026-06-05

- In-package `dna-amr` console entry (deterministic AMR mechanism caller, cipro-validated).
- `dna-pathotype` console entry (deterministic VirulenceFinder-marker pathotype resolver + abstention +
  canonical-VF diff; ExPEC recall 0.917).
- Packaging: both decoders ship in the wheel (`[project.scripts]`).

## [pathotype-v0] / [phase-1-shipped] — 2026-05/06

- Phase-1 closeout: NT-frozen-pooling characterized (passes concentrated-signal mechanisms, fails
  distributed). v0 cipro decoder + pathotype v0 resolver shipped. See git history + `wiki/`.
